Fresenius Medical Care AG (FMS) Gains from Investment Securities (2010 - 2025)

Fresenius Medical Care AG (FMS) has reported Gains from Investment Securities for 16 consecutive years, with -$88.7 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Gains from Investment Securities rose 17.92% year-over-year to -$88.7 million; the TTM figure through Sep 2025 stood at -$318.6 million (up 36.93% YoY), while the FY2020 annual figure was -$592000.0, down 101.77% from the prior year.
• Gains from Investment Securities came in at -$88.7 million for Q3 2025 at Fresenius Medical Care AG, down from -$87.5 million in the prior quarter.
• The five-year high for Gains from Investment Securities was -$21.5 million in Q1 2024, with the low at -$231.8 million in Q2 2024.
• Average Gains from Investment Securities over 5 years is -$97.0 million, with a median of -$87.5 million recorded in 2025.
• Across the five-year window, Gains from Investment Securities sank 296.59% in 2023 and soared 62.27% in 2025, its largest moves.
• Year by year, Gains from Investment Securities stood at -$68.6 million in 2021, then surged by 47.18% to -$36.3 million in 2022, then tumbled by 296.59% to -$143.8 million in 2023, then rose by 24.88% to -$108.0 million in 2024, then grew by 17.92% to -$88.7 million in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$88.7 million, -$87.5 million, and -$34.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.